top of page
Recent Posts

UA targeting rhabdomyosarcoma, a rare pediatric cancer with few treatment options

Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the disease comes back (recurs) and to 30 percent if it spreads (metastasizes).

Archive
Search By Tags
bottom of page